
Sign up to save your podcasts
Or
Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic’s Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration. Related Content:
4.6
162162 ratings
Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic’s Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration. Related Content:
129 Listeners
313 Listeners
853 Listeners
488 Listeners
695 Listeners
264 Listeners
255 Listeners
3,317 Listeners
17 Listeners
19 Listeners
13 Listeners
23 Listeners
89 Listeners
1,069 Listeners
29 Listeners
169 Listeners
506 Listeners
317 Listeners
239 Listeners
17 Listeners
365 Listeners